http://tvnz.co.nz/world-news/ebola-vaccines-and-treatments-being-considered-6058031
Scientists are racing to begin the first human safety tests of two experimental Ebola vaccines.
A vaccine developed by researchers at the National Institutes of Health has been fast-tracked by regulators and is expected to begin its first human safety trial this fall. The vaccine is based on a chimpanzee adenovirus, a relative of cold viruses.British drugmaker GlaxoSmithKline is currently ushering the potential treatment through the development process, after acquiring its original developer, vaccine specialist Okairos AG for, $325 million last year. Studies show the vaccine could protect monkeys from the virus
